David Alagille

2.2k total citations
87 papers, 1.7k citations indexed

About

David Alagille is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, David Alagille has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 16 papers in Physiology. Recurrent topics in David Alagille's work include Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (16 papers) and Medical Imaging Techniques and Applications (10 papers). David Alagille is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (16 papers) and Medical Imaging Techniques and Applications (10 papers). David Alagille collaborates with scholars based in United States, France and Japan. David Alagille's co-authors include Gilles Tamagnan, Ronald M. Baldwin, Olivier Barret, John Seibyl, Kenneth Marek, P. Jeffrey Conn, Caroline Papin, Danna Jennings, Thomas Morley and Adriana Tavares and has published in prestigious journals such as Brain, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

David Alagille

85 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Alagille United States	23	694	601	401	282	253	87	1.7k
Krystyna M. Wozniak United States	28	1.0k 1.5×	1.2k 2.0×	185 0.5×	363 1.3×	168 0.7×	70	2.5k
Zhude Tu United States	33	1.9k 2.7×	817 1.4×	507 1.3×	327 1.2×	394 1.6×	128	3.0k
Sofie Celen Belgium	23	528 0.8×	236 0.4×	343 0.9×	169 0.6×	97 0.4×	55	1.4k
Qi-Huang Zheng United States	26	681 1.0×	327 0.5×	354 0.9×	110 0.4×	107 0.4×	93	1.9k
Susan Boyce United Kingdom	18	825 1.2×	627 1.0×	153 0.4×	842 3.0×	140 0.6×	24	2.0k
Joël Mercier Belgium	24	718 1.0×	889 1.5×	451 1.1×	467 1.7×	209 0.8×	44	2.5k
Katsushi Kumata Japan	25	748 1.1×	524 0.9×	188 0.5×	369 1.3×	150 0.6×	115	2.0k
Celia Dominguez United States	27	1.1k 1.6×	412 0.7×	697 1.7×	142 0.5×	140 0.6×	79	2.2k
Winnie Deuther‐Conrad Germany	26	1.3k 1.9×	579 1.0×	411 1.0×	454 1.6×	103 0.4×	159	2.5k
Masayuki Fujinaga Japan	23	625 0.9×	476 0.8×	224 0.6×	173 0.6×	80 0.3×	111	1.6k

Countries citing papers authored by David Alagille

Since Specialization

Citations

This map shows the geographic impact of David Alagille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Alagille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Alagille more than expected).

Fields of papers citing papers by David Alagille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Alagille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Alagille. The network helps show where David Alagille may publish in the future.

Co-authorship network of co-authors of David Alagille

This figure shows the co-authorship network connecting the top 25 collaborators of David Alagille. A scholar is included among the top collaborators of David Alagille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Alagille. David Alagille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koike, Tatsuki, Cristian Constantinescu, Shuhei Ikeda, et al.. (2021). Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase. European Journal of Nuclear Medicine and Molecular Imaging. 49(4). 1148–1156. 12 indexed citations

Bohórquez, Sandra Sanabria, Jan Mařı́k, Annie Ogasawara, et al.. (2019). [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2077–2089. 82 indexed citations

Constantinescu, Cristian, Cédric Tresse, Ming‐Qiang Zheng, et al.. (2018). Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers. Molecular Imaging and Biology. 21(3). 509–518. 52 indexed citations

Tavares, Adriana, Olivier Barret, David Alagille, et al.. (2014). Brain distribution of MS565, an imaging analogue of siponimod (BAF312), in non-human primates. European Journal of Neurology. 21. 504–504. 6 indexed citations

Tavares, Adriana, Olivier Barret, David Alagille, et al.. (2014). Brain Distribution of MS565, an Imaging Analogue of Siponimod (BAF312), in Non-human Primates (P1.168). Neurology. 82(10_supplement). 9 indexed citations

Barret, Olivier, Jonas Hannestad, David Alagille, et al.. (2014). Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys. Journal of Nuclear Medicine. 55(10). 1712–1718. 29 indexed citations

Barret, Olivier, David Thomae, Adriana Tavares, et al.. (2014). In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: ¹⁸F-MNI-659 and ¹⁸F-MNI-654. Journal of Nuclear Medicine. 55(8). 1297–1304. 51 indexed citations

Tavares, Adriana, Jeffery C. Batis, Olivier Barret, et al.. (2013). In vivo evaluation of [123I]MNI-420: A novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain. Nuclear Medicine and Biology. 40(3). 403–409. 12 indexed citations

Liang, Steven H., Daniel Yokell, Peter A. Rice, et al.. (2013). Microfluidic continuous-flow radiosynthesis of [¹⁸F]FPEB suitable for human PET imaging. MedChemComm. 5(4). 432–435. 25 indexed citations

10.

Barret, Olivier, David Thomae, David Alagille, et al.. (2012). First in vivo assessment of two PDE10 tracers [18F]MNI654 and [18F]MNI659. 53(1). 361–361. 9 indexed citations

11.

Batis, Jeffery C., Olivier Barret, David Alagille, et al.. (2012). In vivo evaluation of [123I]mZIENT as a SPECT radioligand for the serotonin transporter. Nuclear Medicine and Biology. 39(8). 1137–1141. 1 indexed citations

12.

Alagille, David, Yelin Chen, Ruedee Hemstapat, et al.. (2011). Potent mGluR5 antagonists: Pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series. Bioorganic & Medicinal Chemistry Letters. 21(11). 3243–3247. 12 indexed citations

13.

Hemstapat, Ruedee, Tomas de Paulis, Yelin Chen, et al.. (2006). A Novel Class of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Interact with a Site Distinct from That of Negative Allosteric Modulators. Molecular Pharmacology. 70(2). 616–626. 58 indexed citations

14.

Tamagnan, Gilles, David Alagille, Julie K. Staley, et al.. (2006). Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorganic & Medicinal Chemistry Letters. 17(2). 533–537. 19 indexed citations

15.

Tamagnan, Gilles, David Alagille, Xing Fu, et al.. (2005). Synthesis and monoamine transporter affinity of new 2β-carbomethoxy-3β-[aryl or heteroaryl]phenyltropanes. Bioorganic & Medicinal Chemistry Letters. 16(1). 217–220. 4 indexed citations

16.

Tamagnan, Gilles, David Alagille, Xing Fu, et al.. (2004). Synthesis and monoamine transporter affinity of new 2β-carbomethoxy-3β-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency. Bioorganic & Medicinal Chemistry Letters. 15(4). 1131–1133. 11 indexed citations

17.

Alagille, David, et al.. (1965). [Utilization of epsilon-amino-caproic acid in hemostasis in stomatology in hemophiliacs].. PubMed. 66(4). 197–203. 2 indexed citations

18.

Alagille, David, et al.. (1959). [Treatment of Willebrand's disease (angiohemophilia) by coagulant fractions (Fr I-A, Fr I and P.P.B.)].. PubMed. 7. 2463–8. 2 indexed citations

19.

Alagille, David, et al.. (1958). [Thrombopathies associated with congenital cardiopathies; study of hemostasis in 50 cases].. PubMed. 3(4). 322–31. 3 indexed citations

20.

Alagille, David. (1954). [Practical incidences in analyzing hemophilia].. PubMed. 42(5). 213–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact